Table 1 Expression, immune response, clinical correlation and function of ANX2 in cancer
From: Three are better than one: plasminogen receptors as cancer theranostic targets
| Cancer tissue | Expression | Immune response | Clinical correlation | Function |
|---|---|---|---|---|
| Bone | protein [110] | Metastasis [110] | ||
| Brain | protein [97, 98] | Diagnosis [98] | ||
| Breast | mRNA [99] | Chemoresistance, Growth, Metastasis [99, 114–116, 118] | ||
| Colon | mRNA, protein [86, 89, 96] | Prognosis [86] | ||
| Gastric | protein [85] | Prognosis [85] | ||
| Head and neck | mRNA, protein [100] [105–109] | Ab [119, 120] | Prognosis [100] | |
| Hematopoietic system | mRNA [95] protein [68, 91] | Growth, Metastasis [68, 91] | ||
| Kidney | protein [84, 101] | Survival, Prognosis [101] | Metastasis [121] | |
| Liver | mRNA, protein [88, 90, 92, 93] | Diagnosis, Prognosis [90, 93, 103] | ||
| Lung | protein [82] | Ab [122] | Growth, Metastasis [117] | |
| Ovary | Ab [123] | |||
| Pancreas | mRNA, protein [81, 87] | Ab [65, 124] | Survival, Prognosis [65, 104] | Chemoresistance, EMT, Metastasis [65, 104] |
| Prostate | protein [102, 111–113] | Prognosis [102] | Growth, Metastasis [47, 102] | |
| Skin | T cells [125] | |||
| Thyroid | mRNA [83, 94] |